Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

Ispire to Participate in Benzinga Capital Conference in Florida

Events by 2FIRSTS.ai
Apr.10.2024
Ispire to Participate in Benzinga Capital Conference in Florida
Ispire to attend Benzinga Capital Conference in Florida, CEO Michael Wang to speak on product demand growth.

According to a report by PR Newswire on April 10th, Ispire (NASDAQ: ISPR) announced that the company will be participating in the Benzinga Capital Conference, taking place at the Diplomat Beach Resort in Hollywood, Florida on April 16th and 17th.

 

Co-CEO Michael Wang of the company will meet with investors on the morning of April 17, 2024, at 11:00 am Eastern Time in the United States, and will participate in a seminar titled "Puff to Profit: How a Sneaky Product Snuck up the Demand Rankings" and deliver a speech.

 

References:
[1] 雾麻科技将于2024年4月17日参加Benzinga资本大会并发表演讲-美通社PR-Newswire
Also Read:
[1] Ispire's Stock Price Decreases by 5.7% on Nasdaq
[2] Ispire Malaysia Attains ISO Certification, Avoiding 25% Transportation Tariffs
[3] Aspire Signs Exclusive Global Manufacturing and Distribution Agreement with BrkFst
#North America#United States#Open system e-cigarettes#Market#Major companies

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

INTER-TABAC
INTER-TABAC
JT Launches Ploom CUBE Heated Tobacco Device Featuring SMART HEATFLOW
JT Launches Ploom CUBE Heated Tobacco Device Featuring SMART HEATFLOW
Japan Tobacco has launched the Ploom CUBE heated-tobacco device in Japan, with a starter kit retail price of JPY 1,980 (approximately US$13). The cube-shaped device employs the same SMART HEATFLOW heating technology as Ploom AURA and delivers roughly 19–27 sticks per charge.
Oct.09 by 2FIRSTS.ai
Chelyabinsk Doctor Warns of E-Cigarette Dangers After Explosion Incident in Russia, No Injuries Reported
Chelyabinsk Doctor Warns of E-Cigarette Dangers After Explosion Incident in Russia, No Injuries Reported
Doctor Anton Ryzhiy warns of the dangers of e-cigarettes after explosion in Chelyabinsk, Russia, highlighting concerns for youth health.
Sep.17 by 2FIRSTS.ai
Shunho Half-Year Report: New Tobacco Revenue Up 278% YoY to 10.2 Million Yuan, E-Cigarette Segment Revenue 15.59 Million Yuan
Shunho Half-Year Report: New Tobacco Revenue Up 278% YoY to 10.2 Million Yuan, E-Cigarette Segment Revenue 15.59 Million Yuan
In the first half of 2025, Shanghai Shunho New Materials Science & Technology Co., Ltd. recorded revenue of 619 million yuan, down 12.19% year-on-year, and net profit of 33.3 million yuan, up 23.11% year-on-year. Printed products and metallized paper remained the company’s main revenue drivers, but the new tobacco business delivered standout growth, generating 10.2 million yuan in revenue—a surge of 277.83% compared with the same period last year. The e-cigarette segment posted revenue of 15.59
Aug.15 by 2FIRSTS.ai
Russian Lawmakers Propose Criminalizing E-Cigarette Manufacture and Distribution, Citing Health Risks
Russian Lawmakers Propose Criminalizing E-Cigarette Manufacture and Distribution, Citing Health Risks
Russian lawmakers propose criminalizing e-cigarette manufacturing, storage, sales, and use, citing drug crime model for penalties.
Oct.14 by 2FIRSTS.ai
UK MHRA Approved E-cigarette Products List Updated｜Number of Approved SKUs Surges to 1,156, with cartridges Accounting for 1,033 (August 11–17)
UK MHRA Approved E-cigarette Products List Updated｜Number of Approved SKUs Surges to 1,156, with cartridges Accounting for 1,033 (August 11–17)
Between August 11 and August 17, the UK Medicines and Healthcare products Regulatory Agency (MHRA) e-cigarette product notification database published 1,156 SKUs. These updates included rechargeable devices, refillable devices, device kits, and independent pods/components from brands such as ELFBAR, HQD, OXBAR, MOKI, HAYATI, and JNR.
Aug.19 by 2FIRSTS.ai
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
A World Health Organization (WHO) official, Dr. Roa, recently questioned the U.S. Food and Drug Administration’s (FDA) scientific assessment of e-cigarettes and nicotine pouches, claiming there was no independent consensus and suggesting its conclusions may have been influenced by the industry. Her remarks contradict the consensus of leading international scientific bodies and are seen as a direct challenge to FDA’s credibility and to the integrity of public health science.
Aug.20 by 2FIRSTS.ai
Related Topics
News Company
Related Read
JT Launches Ploom CUBE Heated Tobacco Device Featuring SMART HEATFLOW
JT Launches Ploom CUBE Heated Tobacco Device Featuring SMART HEATFLOW
2FIRSTS.ai
Chelyabinsk Doctor Warns of E-Cigarette Dangers After Explosion Incident in Russia, No Injuries Reported
Chelyabinsk Doctor Warns of E-Cigarette Dangers After Explosion Incident in Russia, No Injuries Reported
2FIRSTS.ai
Shunho Half-Year Report: New Tobacco Revenue Up 278% YoY to 10.2 Million Yuan, E-Cigarette Segment Revenue 15.59 Million Yuan
Shunho Half-Year Report: New Tobacco Revenue Up 278% YoY to 10.2 Million Yuan, E-Cigarette Segment Revenue 15.59 Million Yuan
2FIRSTS.ai
Russian Lawmakers Propose Criminalizing E-Cigarette Manufacture and Distribution, Citing Health Risks
Russian Lawmakers Propose Criminalizing E-Cigarette Manufacture and Distribution, Citing Health Risks
2FIRSTS.ai
UK MHRA Approved E-cigarette Products List Updated｜Number of Approved SKUs Surges to 1,156, with cartridges Accounting for 1,033 (August 11–17)
UK MHRA Approved E-cigarette Products List Updated｜Number of Approved SKUs Surges to 1,156, with cartridges Accounting for 1,033 (August 11–17)
2FIRSTS.ai
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文